key: cord-0897430-nl5dqxwl
authors: Mieczkowska, Karolina; Zhu, Tian Hao; Hoffman, Lauren; Blasiak, Rachel C.; Shulman, Kenneth J.; Birnbaum, Mathew; Ciocon, David H.; Srikantha, Rithu; McLellan, Beth N.
title: Two Adult Cases of Multisystem Inflammatory Syndrome Associated with SARS-CoV-2
date: 2021-02-23
journal: JAAD Case Rep
DOI: 10.1016/j.jdcr.2021.02.015
sha: 64bfe7b869ad01ee5fbd1ce31d695f2b1f83aa66
doc_id: 897430
cord_uid: nl5dqxwl

nan

Since the emergence of SARS-CoV-2 worldwide, various manifestations and sequelae 2 have been reported including COVID-19-associated Kawasaki-like multisystem inflammatory 3 syndrome in children (MIS-C) . This dysregulated immune sequelae often presents with features 4 of hypotension or shock, cardiac dysfunction, arterial or venous thromboembolism, 5 gastrointestinal discomfort, and protean skin manifestations. 1 More recently, the CDC has 6 acknowledged increasing incidence of multisystem inflammatory syndrome in adults (MIS-A). 7

The diagnostic criteria for MIS-A includes individuals aged ≥21, positive SARS-CoV-2 testing 8 indicating recent infection, multi-organ dysfunction without severe respiratory illness, and 9 elevated inflammatory markers. 2 We describe two adult patients with signs and symptoms 10 compatible with MIS-A for which dermatologic findings were the presenting symptoms. 11 J o u r n a l P r e -p r o o f A 32-year-old male with no significant past medical history (PMH) presented to the 13 emergency department (ED) with 3 days of subjective fevers, right groin lymphadenopathy 14 confirmed on CT imaging, and an erythematous, burning rash localized to the palms and soles 15 (Fig. 1a) . He had experienced symptoms consistent with COVID-19 2 months prior (fever, 16 anosmia and ageusia, myalgias, and cough) but was not tested by PCR at that time. He was 17 started on trimethoprim-sulfamethoxazole (TMP-SMX) for suspected groin cellulitis of unclear 18 etiology. Over the following week, he developed mild facial swelling, nonexudative bilateral 19 conjunctival injection, lingual erythema, palatal petechiae, diffuse lacy erythematous rash, 20 significant palmar desquamation (Fig. 1b) , acral paresthesias, and there was a notable absence of 21 any respiratory symptoms. DRESS was considered but because the fevers, lymphadenopathy, 22

and onset of rash preceded the use of TMP-SMX, this diagnosis was not pursued. He returned to 23 the ED where a further work-up revealed negative SARS-CoV-2 PCR obtained by a 24 nasopharyngeal swab but positive IgG antibodies, transaminitis (AST 125 U/L, ALT 297 U/L), 25 direct hyperbilirubinemia (2.1 mg/dL), and elevated inflammatory markers including fibrinogen 26 (597 mg/dL), procalcitonin (0.26 ng/mL), ferritin (706 ng/mL), erythrocyte sedimentation rate 27 (ESR; 91 mm/hr), C-reactive protein (CRP; 44.7 mg/dL), D-dimer (334 ng/mL), and IL-6 (48.9 28 pg/mL). Tachycardia was also present, and this prompted an echocardiogram revealing a mildly 29 decreased ejection fraction (EF; 55%) and a small pericardial effusion. A punch biopsy from the 30 patient's back was performed that showed perivascular mononuclear lymphocytic infiltrate with 31 a few eosinophils and parakeratosis. 32

While the patient's symptoms and labs began to improve during the following week, he 33 subsequently developed fever (101.4°F) and diarrhea, and was therefore admitted. Labs showed leukocytosis (16.9 k/uL), thrombocytosis (509 /nL), and persistently elevated inflammatory 35 markers. A chest radiograph was normal and repeat echocardiogram revealed a slightly increased 36 pericardial effusion. All other infectious work-up was negative. Repeat SARS-CoV-2 PCR 37 obtained by a nasopharyngeal swab returned positive and in light of the constellation of findings, 38 the patient was diagnosed with post-COVID-19 multisystem inflammatory syndrome. A CT 39 angiogram of the heart was performed, which showed no evidence of coronary artery aneurysm. 40

The patient received therapy with enoxaparin and intravenous methylprednisolone (2mg/kg). 41

Following discharge on a two-week prednisone taper, the patient had a complete recovery. 42 J o u r n a l P r e -p r o o f A 43-year-old female with no significant PMH presented to the ED with a 10-day history 44 of myalgias, headache, and recurring fevers despite antipyretic use, accompanied by cough for 5 45 days and a pruritic rash for 3 days. Physical findings included decreased breath sounds at the 46 right lung base with x-ray findings suggestive of a right basilar pneumonia and an erythematous, 47 morbilliform eruption that began on the palms and upper extremities, before then spreading to 48 the trunk and lower extremities sparing the face, suggestive of a viral exanthem (Fig. 2) . In 

Kawasaki disease, toxic shock syndrome, and hemophagocytic lymphohistiocytosis, which are 67 closely linked to underlying immune dysregulation. 3 In contrast to the acute cytokine storm 68 observed in the early phase of COVID-19, MIS-A has been observed to occur later in the disease 69 progression, often after an initial recovery period when nucleic acid testing may be negative but 

Multisystem Inflammatory Syndrome in 109

Children During the Coronavirus 2019 Pandemic: A Case Series

Syndrome in Adults Associated with SARS-CoV-2 Infection -United Kingdom and 113

United States

An adult with Kawasaki-like multisystem 116 inflammatory syndrome associated with COVID-19

Multisystem inflammatory syndrome 118 in an adult with SARS-CoV-2 infection

COVID-19 and multisystem inflammatory syndrome in children (MIS-C)-like illness: a 121 case report

Kawasaki-like multisystem inflammatory disease in an adult

Coronavirus disease 2019-related Kawasaki-like disease in an adult: A case report